• 1
    Jones RJ, Barber JP, Vala MS et al. Assessment of aldehyde dehydrogenase in viable cells. Blood 1995; 85: 27422746.
  • 2
    Storms RW, Trujillo AP, Springer JB et al. Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. Proc Natl Acad Sci USA 1999; 96: 91189123.
  • 3
    D'Angelo RC, Wicha MS. Stem cells in normal development and cancer. Prog Mol Biol Transl Sci 2010; 95: 113158.
  • 4
    Alison MR, Guppy NJ, Lim SM et al. Finding cancer stem cells: Are aldehyde dehydrogenases fit for purpose? J Pathol 2010; 222: 335344.
  • 5
    Ma I, Allan AL. The role of human aldehyde dehydrogenase in normal and cancer stem cells. Stem Cell Rev 2010 (in press). Doi: 10.1007/s12015–010-9208–4.
  • 6
    Moreb JS. Aldehyde dehydrogenase as a marker for stem cells. Curr Stem Cell Res Ther 2008; 3: 237246.
  • 7
    Marchitti SA, Brocker C, Stagos D et al. Non-P450 aldehyde oxidizing enzymes: The aldehyde dehydrogenase superfamily. Expert Opin Drug Metab Toxicol 2008; 4: 697720.
  • 8
    Kastan MB, Schlaffer E, Russo JE et al. Direct demonstration of elevated aldehyde dehydrogenase in humanhematopoietic progenitor cells. Blood 1990; 74: 19451950.
  • 9
    Ginestier C, Hur MH, Charafe-Jauffret E et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007; 1: 555567.
  • 10
    Marcato P, Dean C, Pan D et al. Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis. Stem Cells 2011; 29: 3245.
  • 11
    Chute JP, Muramoto GG, Whitesides J et al. Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells. Proc Natl Acad Sci USA 2006; 103: 1170711712.
  • 12
    Muramoto GG, Russell JL, Safi R et al. Inhibition of aldehyde dehydrogenase expands hematopoietic stem cells with radioprotective capacity. Stem Cells 2010; 28: 523534.
  • 13
    Dolle P. Developmental expression of retinoic acid receptors (RARs). Nucl Recept Signal 2009; 7: e006.
  • 14
    Mark M, Ghyselinck NB, Chambon P. Function of retinoic acid receptors during embryonic development. Nucl Recept Signal 2009; 7: e002.
  • 15
    Rovira M, Scott SG, Liss AS et al. Isolation and characterization of centroacinar/terminal ductal progenitor cells in adult mouse pancreas. Proc Natl Acad Sci USA 2010; 107: 7580.
  • 16
    Levi BP, Yilmaz OH, Duester G et al. Aldehyde dehydrogenase 1a1 is dispensable for stem cell function in the mouse hematopoietic and nervous systems. Blood 2009; 113: 16701680.
  • 17
    Ma AC, Chung MI, Liang R et al. A DEAB-sensitive aldehyde dehydrogenase regulates hematopoietic stem and progenitor cells development during primitive hematopoiesis in zebrafish embryos. Leukemia 2010; 24: 20902099.
  • 18
    Mohyeldin A, Garzon-Muvdi T, Quinones-Hinojosa A. Oxygen in stem cell biology: A critical component of the stem cell niche. Cell Stem Cell 2010; 7: 150161.
  • 19
    Hess DA, Meyerrose TE, Wirthlin L et al. Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. Blood 2004; 104: 16481655.
  • 20
    Storms RW, Green PD, Safford KM et al. Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34. Blood 2005; 106: 95102.
  • 21
    Hess DA, Wirthlin L, Craft TP et al. Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells. Blood 2006; 107: 21622169.
  • 22
    Pearce DJ, Bonnet D. The combined use of Hoechst efflux ability and aldehyde dehydrogenase activity to identify murine and human hematopoietic stem cells. Exp Hematol 2007; 35: 14371446.
  • 23
    Christ O, Lucke K, Imren S et al. Improved purification of hematopoietic stem cells based on their elevated aldehyde dehydrogenase activity. Haematologica 2007; 92: 11651172.
  • 24
    Liu C, Chen BJ, Deoliveira D et al. Progenitor cell dose determines the pace and completeness of engraftment in a xenograft model for cord blood transplantation. Blood 2010; 116: 55185527.
  • 25
    Gentry T, Foster S, Winstead L et al. Simultaneous isolation of human BM hematopoietic, endothelial and mesenchymal progenitor cells by flow sorting based on aldehyde dehydrogenase activity: Implications for cell therapy. Cytotherapy 2007; 9: 259274.
  • 26
    Capoccia BJ, Robson DL, Levac KD et al. Revascularization of ischemic limbs after transplantation of human bone marrow cells with high aldehyde dehydrogenase activity. Blood 2009; 113: 53405351.
  • 27
    Mirabelli P, Di NR, Lo PC et al. Extended flow cytometry characterization of normal bone marrow progenitor cells by simultaneous detection of aldehyde dehydrogenase and early hematopoietic antigens: Implication for erythroid differentiation studies. BMC Physiol 2008; 8: 13.
  • 28
    Fallon P, Gentry T, Balber AE et al. Mobilized peripheral blood SSCloALDHbr cells have the phenotypic and functional properties of primitive haematopoietic cells and their number correlates with engraftment following autologous transplantation. Br J Haematol 2003; 122: 99108.
  • 29
    Gunduz E, Demirel G, Bal C et al. Evaluation of mobilized peripheral stem cells according to CD34 and aldehyde dehydrogenase expression and effect of SSC(lo) ALDH(br) cells on hematopoietic recovery. Cytotherapy 2010; 12: 10061012.
  • 30
    Taubert I, Saffrich R, Zepeda-Moreno A et al. Characterization of hematopoietic stem cell subsets from patients with multiple myeloma after mobilization with plerixafor. Cytotherapy. 2010 (in press). Doi: 10.3109/14653249.2010.530652.
  • 31
    Lioznov M, Dellbrugger C, Sputtek A et al. Transportation and cryopreservation may impair haematopoietic stem cell function and engraftment of allogeneic PBSCs, but not BM. Bone Marrow Transplant 2008; 42: 121128.
  • 32
    Page KM, Gentry T, Shoulars K et al. Use of aldehyde dehydrogenase content to predict dominating cord in double cord blood transplant. Biol Bone Marrow Transplant 2010; 16: 2155.
  • 33
    Shoulars K, Gentry T, Page KM et al. Creation of a segment-based aldehyde dehydrogenase assay as a biomarker for cord blood potency. Biol Bone Marrow Transplant 2010; 16: 263.
  • 34
    Kurtzberg J, Mendizabal A, Reese M et al. Augmentation of standard umbilical cord blood transplantation with ALDHbr cells: Results of a phase I study in pediatric patients. Biol Bone Marrow Transplant 2008; 14: 105.
  • 35
    Povsic TJ, Zavodni KL, Vainorius E et al. Common endothelial progenitor cell assays identify discrete endothelial progenitor cell populations. Am Heart J 2009; 157: 335344.
  • 36
    Povsic TJ, Zavodni KL, Kelly FL et al. Circulating progenitor cells can be reliably identified on the basis of aldehyde dehydrogenase activity. J Am Coll Cardiol 2007; 50: 22432248.
  • 37
    Sondergaard CS, Hess DA, Maxwell DJ et al. Human cord blood progenitors with high aldehyde dehydrogenase activity improve vascular density in a model of acute myocardial infarction. J Transl Med 2010; 8: 2437.
  • 38
    Smith L, White H, Gentry T et al. Human ALDH-bright bone marrow cells produce paracrine factors that protect endothelial cells from hypoxic and nutritional stress. Blood 2009; 114: 3056.
  • 39
    Povsic TJ, Zhou J, Adams SD et al. Aging is not associated with bone marrow-resident progenitor cell depletion. J Gerontol A Biol Sci Med Sci 2010; 65: 10421050.
  • 40
    Dimmeler S, Leri A. Aging and disease as modifiers of efficacy of cell therapy. Circ Res 2008; 102: 13191330.
  • 41
    Perin EC, Silva G, Gahremanpour A et al. A randomized, controlled study of autologous therapy with bone marrow-derived aldehyde dehydrogenase bright cells in patients with critical limb ischemia. Catheter Cardiovasc Interv 2011 (in press).
  • 42
    Perin EC, Silva GV, Zheng Y et al. First in man transendocardial injection of autologous aldehyde dehydrogenase bright cells in hear failure patients (FOCUS-Bright). Circulation 2009; 120: S812.
  • 43
    Hess DA, Craft TP, Wirthlin L et al. Widespread nonhematopoietic tissue distribution by transplanted human progenitor cells with high aldehyde dehydrogenase activity. Stem Cells 2008; 26: 611620.
  • 44
    Zhou P, Hohm S, Olusanya Y et al. Human progenitor cells with high aldehyde dehydrogenase activity efficiently engraft into damaged liver in a novel model. Hepatology 2009; 49: 19922000.
  • 45
    Cai J, Cheng A, Luo Y et al. Membrane properties of rat embryonic multipotent neural stem cells. J Neurochem 2004; 88: 212226.
  • 46
    Corti S, Locatelli F, Papadimitriou D et al. Identification of a primitive brain-derived neural stem cell population based on aldehyde dehydrogenase activity. Stem Cells 2006; 24: 975985.
  • 47
    Obermair FJ, Fiorelli R, Schroeter A et al. A novel classification of quiescent and transit amplifying adult neural stem cells by surface and metabolic markers permits a defined simultaneous isolation. Stem Cell Res 2010; 5: 131143.
  • 48
    Corti S, Locatelli F, Papadimitriou D et al. Transplanted ALDHhiSSClo neural stem cells generate motor neurons and delay disease progression of nmd mice, an animal model of SMARD1. Hum Mol Genet 2006; 15: 167187.
  • 49
    Corti S, Nizzardo M, Nardini M et al. Neural stem cell transplantation can ameliorate the phenotype of a mouse model of spinal muscular atrophy. J Clin Invest 2008; 118: 33163330.
  • 50
    Vauchez K, Marolleau JP, Schmid M et al. Aldehyde dehydrogenase activity identifies a population of human skeletal muscle cells with high myogenic capacities. Mol Ther 2009; 17: 19481958.
  • 51
    Jean E, Laoudj-Chenivesse D, Notarnicola C et al. Aldehyde dehydrogenase activity promotes survival of human muscle precursor cells. J Cell Mol Med 2011; 15: 119133.
  • 52
    Nagano M, Kimura K, Yamashita T et al. Hypoxia responsive mesenchymal stem cells derived from human umbilical cord blood are effective for bone repair. Stem Cells Dev 2010; 19: 11951210.
  • 53
    Estes BT, Wu AW, Storms RW et al. Extended passaging, but not aldehyde dehydrogenase activity, increases the chondrogenic potential of human adipose-derived adult stem cells. J Cell Physiol 2006; 209: 987995.
  • 54
    Nagano M, Yamashita T, Hamada H et al. Identification of functional endothelial progenitor cells suitable for the treatment of ischemic tissue using human umbilical cord blood. Blood 2007; 110: 151160.
  • 55
    Martignani E, Eirew P, Accornero P et al. Human milk protein production in xenografts of genetically engineered bovine mammary epithelial stem cells. PLoS One 2010; 5: e13372.
  • 56
    Burger PE, Gupta R, Xiong X et al. High aldehyde dehydrogenase activity: A novel functional marker of murine prostate stem/progenitor cells. Stem Cells 2009; 27: 22202228.
  • 57
    Ahmad S, Kolli S, Li DQ et al. A putative role for RHAMM/HMMR as a negative marker of stem cell-containing population of human limbal epithelial cells. Stem Cells 2008; 26: 16091619.